fluoxymesterone has been researched along with Breast Cancer in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 72 (76.60) | 18.7374 |
1990's | 17 (18.09) | 18.2507 |
2000's | 4 (4.26) | 29.6817 |
2010's | 1 (1.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bassett, R; Fujii, T; Gong, Y; Huo, L; Karuturi, MS; Kono, M; Lyons, GR; Tripathy, D; Ueno, NT | 1 |
KENNEDY, BJ | 2 |
STOLL, BA | 3 |
OLSON, KB | 1 |
BECKETT, VL; BRENNAN, MJ | 1 |
DE LORIMIER, AA; GOLDMAN, L; GORDAN, GS; LOWE, R | 1 |
PIACENTINI, G | 1 |
BECKETT, VL; BRENNAN, MJ; TALLEY, RW; VAITKEVICIUS, VK | 1 |
KOROS, Z; SELLEI, C | 1 |
GARDNER, B; GORDAN, GS; GRAHAM, WP; THOMAS, AN; WITT, JA | 1 |
BRENNAN, MJ; LEIGHTON, GA; REED, ML; SANDIEGO, EL; TALLEY, RW; VAITKEVICIUS, VK | 1 |
GOLDENBERG, IS; HAYES, MA; MORIN, JE | 1 |
HUDSON, B | 1 |
Donohue, JH; Goetz, MP; Ingle, JN; Krook, JE; Kugler, JW; Mailliard, JA; Michalak, JC; Perez, EA; Pisansky, TM; Suman, VJ; Wold, LE | 1 |
Cheung, A; Driedger, AA | 1 |
Bloom, ND; Brigati, DJ; Carter, AC; Degenshein, GA; Gaetjens, E; Pertschuk, LP; Tobin, EH | 1 |
Miura, S; Yoshida, M | 1 |
Bezwoda, WR; Browde, S; Derman, DP; Goss, G; Lange, M | 1 |
Murayama, Y | 1 |
Ammirata, S; Dilley, WG; Haagensen, DE; Leight, GS; Silva, JS; Wells, SA | 1 |
Rubens, RD; Steiner, R; Stewart, JF | 1 |
Hart, RD; Holland, JF; Perloff, M | 2 |
Cassidy, JG; Edwards, BK; Lippman, ME; Tormey, DC | 1 |
Bieger, R; in 't Veld, CJ; Mosmans, PC | 1 |
Westerberg, H | 1 |
Forrest, AP; Gunn, JM; Hamilton, T; Langlands, AO; McFadyen, IJ; Roberts, MM; Stewart, HJ | 1 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Leuenberger, U; Ryssel, HJ; Sonntag, RW | 1 |
Agrawal, BL | 1 |
Arafah, BM; Manni, A; Pearson, OH | 1 |
Arseneau, JC; Band, PR; Bauer, M; Falkson, G; Gelman, R; Sears, M; Tormey, DC | 1 |
Barton, TK; Cox, C; Haagensen, DE; McCarty, KS; Mossler, JA; Silva, JS; Wells, SA; Woodard, BH | 1 |
Arafah, BM | 1 |
Abrams, J; Aisner, J; Budman, D; Cirrincione, C; Citron, M; Holland, J; Muss, H; Panasci, L; Perloff, M; Perry, M | 1 |
Falkson, CI; Falkson, G; Gelman, R; Glick, J; Harris, J | 2 |
Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
Aust, JC; Bank, A; Canellos, GP; Carey, RW; Gottlieb, A; Holland, JF; Korzun, AH; Norton, L; Perloff, M; Perry, MC; Saleh, F; Silver, RT; Weiss, RB; Wood, WC | 1 |
Falkson, G; Gilchrist, KW; Neuberg, D; Olson, JE; Pandya, KJ; Richter, MP; Solin, LJ; Tormey, DC; Veeder, M | 1 |
Del Mastro, L; Rosso, R; Sertoli, MR; Venturini, M | 1 |
Chang, AY; Falkson, G; Gelman, R; Harris, J; Pandya, KJ; Putt, M; Tormey, DC | 1 |
Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
Abeloff, M; Falkson, G; Hu, P; Sledge, GW; Tormey, D | 1 |
Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C | 1 |
Bernardo, MV; Harrington, DP | 1 |
Falkson, G; Falkson, HC | 1 |
Horwitz, KB; McGuire, WL | 1 |
Takaya, O | 1 |
Franks, CR; Williams, Y | 1 |
Chihara, K; Imura, H; Kato, Y; Ohgo, S | 1 |
Bull, JM; Lippman, ME; Myers, CE; Simon, RM; Tormey, DC | 1 |
Falkson, CI; Falkson, G; Gelman, RS; Glick, J; Harris, J | 1 |
Aversa, SM; Daniele, O; De Besi, P; Ferrazzi, E; Fiorentino, MV; Fornasiero, A; Ghiotto, C; Sileni, VC | 1 |
Jackson, DV; Muss, HB; Schifeling, DJ; Zekan, PJ | 1 |
Abe, K | 1 |
Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R | 1 |
Bellocq, JP; Chambon, P; Edgerton, SM; Koerner, FC; Rio, MC; Sawicka, JM; Schwartz, LH; Thor, AD | 1 |
Cullinan, SA; Gerstner, JG; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Schaid, DJ; Tschetter, LK; Twito, DI; Windschitl, HE | 1 |
Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC | 1 |
Andersen, JW; Asbury, RF; Benson, AB; Falkson, G; Skeel, RT; Tormey, DC | 1 |
Korzun, AH; Norton, L; Perloff, M; Rice, MA; Wall, JG; Weiss, RB; Wood, WC | 1 |
Adachi, I; Watanabe, T | 1 |
Andersen, J; Poulsen, HS | 1 |
Jaffe, RM; MacLaughlin, WW; Rosen, JM | 1 |
Bagley, C; Lippman, ME; Steinberg, SM; Swain, SM | 1 |
Cullinan, SA; Gerstner, JG; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Marschke, RF; Schaid, DJ; Twito, DI; Windschitl, HE | 1 |
Chang, AY; Davis, TE; Falkson, G; Falkson, HC; Loprinzi, CL; Rasmussen, P; Tormey, DC | 1 |
Kamby, C; Rose, C | 1 |
Ammirata, S; Davis, SR; Dilley, WG; Haagensen, DE; Leight, GS; Lokich, JJ; Silva, JS; Wells, SA; Zamcheck, N | 1 |
Gennatas, CS; Kalovidouris, A; Kouvaris, J; Papavasiliou, C; Paraskevas, GA; Trichopoulos, D | 1 |
Hashizume, Y; Hirano, M; Ishida, K; Iwa, T; Katada, S; Kawaura, Y; Yamada, T | 1 |
Dao, TL; Nemoto, T | 1 |
Burn, I; Fraser-Moodie, A | 1 |
Cole, DR; Davis, HL; Korbitz, BC; McKenna, PJ; Prout, MN | 1 |
Longson, D | 1 |
Gastesi, RA; O'Bryan, RM; Reyes, ES; Talley, RW | 1 |
Burn, I; Fotherby, K; Sellwood, RA | 1 |
Miura, S; Takeuchi, S; Yoshida, Y | 1 |
Bourjat, P; Gautherie, M; Gros, C; Quenneville, Y | 1 |
Haines, CR; Hall, TC; Nevinny, HB; Wallace, HJ | 1 |
Scott, WP | 1 |
Horton, J; Olson, K | 1 |
Byron, RL; Keating, JL; Yonemoto, RH | 1 |
Nathanson, L | 1 |
Oka, T; Shinoda, M | 1 |
Fierer, JA; Strebel, RF; Wagner, BM | 1 |
Kleibel, F | 1 |
Ehlers, PN | 1 |
Buckley, K; Gump, FE; Herter, FP; McCarthy, JG; Mulcare, RJ; Ukai, M; Wheeler, B | 1 |
Demol, R | 1 |
3 review(s) available for fluoxymesterone and Breast Cancer
Article | Year |
---|---|
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications.
Topics: Amenorrhea; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Melphalan; Methotrexate; Premenopause; Prognosis; Thiotepa; Vinblastine | 1997 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
Androgen therapy.
Topics: Anabolic Agents; Androgens; Androstanes; Breast Neoplasms; Climacteric; Female; Fluoxymesterone; Hematologic Diseases; Humans; Hypopituitarism; Male; Methyltestosterone; Testicular Diseases; Testis; Testosterone | 1972 |
33 trial(s) available for fluoxymesterone and Breast Cancer
Article | Year |
---|---|
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluoxymesterone; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Tamoxifen | 2006 |
[Internal endocrine therapy of breast cancer].
Topics: Androstanols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Testosterone | 1984 |
Results of endocrine therapy do not predict response to chemotherapy in advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Diethylstilbestrol; Doxorubicin; Ethinyl Estradiol; Female; Fluoxymesterone; Humans; Middle Aged; Prednisolone; Tamoxifen; Vincristine | 1983 |
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.
Topics: Adult; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Tamoxifen | 1983 |
Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.
Topics: Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Fluoxymesterone; Humans; Menopause; Tamoxifen; Time Factors | 1980 |
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1980 |
Combination hormonotherapy with tamoxifen and fluoxymesterone in patients with advanced breast cancer relapsing on hormonotherapy.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Tamoxifen | 1982 |
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Fluoxymesterone; Hematopoiesis; Humans; Middle Aged; Prospective Studies; Random Allocation | 1981 |
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Regression Analysis; Thiotepa; Treatment Failure; Vinblastine; Vincristine | 1995 |
Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Logistic Models; Middle Aged; Mitolactol; Neoplasm Metastasis; Remission Induction; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 1994 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Postoperative Period; Prednisone; Probability; Survival Analysis; Thiotepa; Vinblastine; Vincristine | 1996 |
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Recurrence; Survival Analysis; Tamoxifen | 1997 |
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Mitolactol; Neoplasm Metastasis; Pilot Projects; Remission Induction; Survival Analysis; Tamoxifen; Vincristine | 1998 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Tamoxifen; Treatment Outcome | 2000 |
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Letter: Calusterone (NSC-88536) in advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Methyltestosterone | 1976 |
2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
Topics: Administration, Oral; Age Factors; Androstanes; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Estrogen Antagonists; Female; Fluoxymesterone; Humans; Liver; Menopause; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Sulfides | 1978 |
Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Stilbenes; Tamoxifen | 1976 |
Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Middle Aged | 1992 |
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Middle Aged; Mitolactol; Multivariate Analysis; Prognosis; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 1991 |
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Receptors, Estrogen; Remission Induction; Survival Rate; Tamoxifen; Weight Gain | 1991 |
[Role of supporting therapy of Juzentaiho-to (JTT) in advanced breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxymesterone; Humans; Leukopenia; Middle Aged; Quality of Life; Random Allocation; Tamoxifen; Thrombocytopenia | 1989 |
Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Danazol; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1988 |
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1988 |
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Clinical Laboratory Techniques; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Prognosis; Prospective Studies; Random Allocation; Tamoxifen; Vincristine | 1986 |
Metastatic pattern and response to endocrine therapy in human breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Medroxyprogesterone; Menopause; Neoplasm Metastasis; Tamoxifen | 1986 |
A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Hydrocortisone; Middle Aged; Random Allocation; Tamoxifen | 1987 |
An evaluation of adrenalectomy and androgen in disseminated mammary carcinoma.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Fluoxymesterone; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis | 1965 |
Clinical evaluation of 1,3-bis(2-chloroethyl)-nitrosourea (BCNU; NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topic; Edema; Fluoxymesterone; Gastrointestinal Diseases; Humans; Neoplasm Metastasis; Neoplasms; Phlebitis; Rectal Neoplasms; Time Factors | 1973 |
Clinical control of metastases in patients with advanced cancer of the breast.
Topics: Breast Neoplasms; Castration; Clinical Trials as Topic; Diethylstilbestrol; Ethinyl Estradiol; Female; Fluoxymesterone; Gonadal Steroid Hormones; Humans; Neoplasm Metastasis; Pituitary Irradiation | 1974 |
Clinical evaluation of estrogen-androgen combination in advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Ethinyl Estradiol; Female; Fluoxymesterone; Hemoglobinometry; Humans; Menopause; Middle Aged; Placebos; Radiography | 1969 |
58 other study(ies) available for fluoxymesterone and Breast Cancer
Article | Year |
---|---|
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Fluoxymesterone; Follow-Up Studies; Gene Expression; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Proportional Hazards Models; Receptors, Androgen; Receptors, Estrogen; Retrospective Studies; Treatment Outcome | 2016 |
Fluoxymesterone therapy in advanced breast cancer.
Topics: Breast; Breast Neoplasms; Fludrocortisone; Fluoxymesterone; Humans; Neoplasms | 1958 |
Fluoxymesterone (halotestin) in advanced breast carcinoma.
Topics: Breast Neoplasms; Fludrocortisone; Fluoxymesterone; Humans | 1959 |
Fluoxymesterone (halotestin) in the treatment of advanced breast cancer.
Topics: Breast; Breast Neoplasms; Fludrocortisone; Fluoxymesterone; Humans; Neoplasms | 1959 |
Treatment of advanced breast cancer with fluoxymesterone (halotestin).
Topics: Breast; Breast Neoplasms; Fludrocortisone; Fluoxymesterone; Humans; Neoplasms | 1959 |
Antitumor efficacy of fluoxymesterone. Use in advanced breast cancer.
Topics: Androgens; Breast Neoplasms; Fluoxymesterone; Hormone Replacement Therapy; Humans; Neoplasms | 1961 |
[Anabolic agents (synthetic androgens) in oncology, with special reference to breast carcinoma].
Topics: Anabolic Agents; Anatomy; Breast Neoplasms; Fluoxymesterone; Humans; Methyltestosterone; Testosterone; Testosterone Congeners | 1962 |
Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation.
Topics: Anatomy; Antineoplastic Agents; Breast Neoplasms; Fluoxymesterone; Humans; Methyltestosterone | 1963 |
[Complex chemotherapeutic treatment of breast cancer].
Topics: Breast Neoplasms; Castration; Fluoxymesterone; Humans; Male; Methyltestosterone; Orchiectomy; Testosterone | 1962 |
Secondary hormonal therapy of disseminated breast cancer. Comparison of hypophysectomy, replacement therapy, estrogens, and androgens.
Topics: Anatomy; Androgens; Antineoplastic Agents; Biological Therapy; Breast Neoplasms; Estrogens; Fluoxymesterone; Humans; Hydrocortisone; Hypophysectomy; Methyltestosterone; Neoplasms; Prednisone; Triiodothyronine | 1963 |
Stimulation of erythropoiesis by androgenic hormones.
Topics: Androgens; Anemia; Breast Neoplasms; Dihydrotestosterone; Erythropoiesis; Fluoxymesterone; Hematopoiesis; Humans; Methyltestosterone; Testosterone | 1962 |
COMPARISON OF 6-ALPHA-METHYL-9-ALPHA-FLUORO-17-ACETOXY-21-DEOXYPREDNISOLONE WITH FLUOXYMESTERONE AND METHYLPREDNISOLONE IN TREATMENT OF METASTATIC BREAST CANCER.
Topics: Biometry; Breast Neoplasms; Drug Therapy; Fludrocortisone; Fluoxymesterone; Humans; Methylprednisolone; Neoplasm Metastasis; Neoplasms | 1964 |
HORMONAL THERAPY OF METASTATIC FEMALE BREAST CARCINOMA. V. PHENOL,4,4'-(DL-1,2-DIETHYL-ETHYLENE)DI- AND ANDROST-4-EN-3-ONE, 9-CHLORO-11-BETA, 17-BETA-DIHYDROXY-17-METHYL-.
Topics: Androgens; Breast Neoplasms; Carcinoma; Diethylstilbestrol; Drug Therapy; Estrogens; Ethylenes; Female; Fluoxymesterone; Humans; Menopause; Neoplasm Metastasis; Phenol; Toxicology | 1965 |
Fluoxymesterone ("halotestin"): a new androgen.
Topics: Androgens; Breast Neoplasms; Fluoxymesterone; Hormone Replacement Therapy; Humans; Osteoporosis | 1959 |
Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Middle Aged; Palliative Care; Parathyroid Hormone; Phosphorus Radioisotopes; Prostatic Neoplasms | 1980 |
Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.
Topics: Adrenalectomy; Binding, Competitive; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Castration; Centrifugation, Density Gradient; Diethylstilbestrol; Female; Fluorescent Antibody Technique; Fluoxymesterone; Histocytochemistry; Humans; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1980 |
Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Menopause; Methotrexate; Tamoxifen; Time Factors | 1984 |
[Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Topics: Breast Neoplasms; Castration; Diethylstilbestrol; Estradiol; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Tamoxifen | 1984 |
Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
Topics: Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoembryonic Antigen; Carrier Proteins; Female; Fluoxymesterone; Glycoproteins; Humans; Kinetics; Membrane Transport Proteins; Neoplasm Metastasis; Neoplasm Proteins | 1983 |
One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Thiotepa; Vinblastine | 1981 |
[Neurological manifestations in treatment with androgenic hormones].
Topics: Aged; Akathisia, Drug-Induced; Bone Neoplasms; Breast Neoplasms; Female; Fluoxymesterone; Humans; Middle Aged | 1983 |
Ataxia caused by fluoxymesterone therapy in breast cancer.
Topics: Aged; Ataxia; Breast Neoplasms; Female; Fluoxymesterone; Humans | 1981 |
Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer.
Topics: Breast Neoplasms; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Hypophysectomy; Neoplasm Metastasis; Tamoxifen; Time Factors | 1981 |
Comparison of sex steroid receptor analyses and carcinoembryonic antigen with clinical response to hormone therapy.
Topics: Adrenalectomy; Breast Neoplasms; Carcinoembryonic Antigen; Castration; Centrifugation, Density Gradient; Estrogen Antagonists; Female; Fluoxymesterone; Humans; Hypophysectomy; Neoplasm Metastasis; Progestins; Receptors, Estrogen; Receptors, Progesterone | 1980 |
Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer.
Topics: Aged; Breast Neoplasms; Female; Fluoxymesterone; Humans; Hypothyroidism; Middle Aged; Palliative Care; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins | 1994 |
Sample size calculations for the two-sample problem using the multiplicative intensity model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Fluoxymesterone; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Likelihood Functions; Markov Chains; Methotrexate; Models, Biological; Prednisone; Randomized Controlled Trials as Topic; Sample Size; Tamoxifen | 2001 |
Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Thiotepa; Time Factors; Vinblastine | 1978 |
Predicting response to endocrine therapy in human breast cancer: a hypothesis.
Topics: Breast Neoplasms; Castration; Centrifugation, Density Gradient; Estrogens; Female; Fluoxymesterone; Humans; Hypophysectomy; Progesterone; Progesterone Congeners; Receptors, Cell Surface | 1975 |
[Clinical effect of fluoxymesterone in the treatment of recurrent and progressive breast neoplasms].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1977 |
The effect of sex hormones on peripheral immunity in patients with advanced breast cancer.
Topics: Breast Neoplasms; Diethylstilbestrol; Ethinyl Estradiol; Female; Fluoxymesterone; Gonadal Steroid Hormones; Humans; Immunity, Cellular | 1978 |
Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluoxymesterone; Humans; Injections, Intravenous; Middle Aged; Prolactin; Thyrotropin-Releasing Hormone | 1976 |
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Mitolactol; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1992 |
Deflazacort and fluoximesterone in advanced, pretreated breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluoxymesterone; Humans; Middle Aged; Pregnenediones | 1992 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine | 1991 |
pS2 expression and response to hormonal therapy in patients with advanced breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluoxymesterone; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 1991 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Leucovorin; Leukopenia; Lung; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Receptors, Estrogen; Tamoxifen; Thrombocytopenia; Time Factors; Vincristine | 1985 |
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Fluoxymesterone; Humans; Leukopenia; Middle Aged; Mitolactol; Neoplasm Recurrence, Local; Nervous System Diseases; Thiotepa; Thrombocytopenia; Vinblastine; Vincristine | 1989 |
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Breast Neoplasms; Cerebrovascular Disorders; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Prednisone; Thiotepa; Thrombosis; Vinblastine; Vincristine | 1989 |
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Immunohistochemistry; Menopause; Middle Aged; Neoplasm Recurrence, Local; Paraffin; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1989 |
Resolution of a photopenic lesion on bone imaging following chemotherapy for metastatic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Doxorubicin; Female; Fluoxymesterone; Humans; Middle Aged; Radionuclide Imaging; Sternum; Thiotepa; Vinblastine | 1987 |
Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.
Topics: Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoembryonic Antigen; Carrier Proteins; Cell Line; Female; Fluoxymesterone; Glycoproteins; Humans; Membrane Transport Proteins; Middle Aged; Receptors, Estrogen | 1986 |
[Treatment of chemo-endocrine therapy in recurrent breast cancer].
Topics: Adult; Androstanols; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Tamoxifen | 1986 |
Vaginal cytology as an aid to hormone therapy in postmenopausal cancer of the breast.
Topics: Antithyroid Agents; Biological Assay; Breast Neoplasms; Castration; Diethylstilbestrol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Fluoxymesterone; Humans; Neoplasm Regression, Spontaneous; Progesterone; Vaginal Smears | 1967 |
The thermoprofile as an early indicator of breast cancer response to hormonal therapy.
Topics: Breast Neoplasms; Diethylstilbestrol; Estrogens, Conjugated (USP); Female; Fluoxymesterone; Humans; Methods; Skin; Skin Temperature; Thermography; Time Factors | 1971 |
Small-bowel metastases from carcinoma of the breast.
Topics: Aged; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Intestinal Neoplasms; Intestinal Obstruction; Intestine, Small; Neoplasm Metastasis | 1974 |
Acute leukemia complicating metastatic breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Vincristine | 1973 |
[Effect of fluoxymesterone (Halotestin) on progressive breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluoxymesterone; Humans; Middle Aged | 1972 |
[Thermogenic capacity of breast carcinomas. II. Variation during hormonal tests].
Topics: Adult; Aged; Androgens; Body Temperature; Breast Neoplasms; Estrogens; Ethinyl Estradiol; Female; Fluoxymesterone; Humans; Middle Aged; Norethindrone; Phosphorus; Phosphorus Radioisotopes; Skin Temperature; Testosterone; Thermography; Thermometers | 1973 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Humans; Male; Methotrexate; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Paraganglia, Nonchromaffin; Prednisone; Prostatic Neoplasms; Thiotepa | 1968 |
[Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Fluoxymesterone; Humans; Injections, Intravenous; Lung Neoplasms; Melanoma; Mitomycins; Thiotepa | 1968 |
Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
Topics: Adrenalectomy; Androgens; Antineoplastic Agents; Breast Neoplasms; Cortisone; Cyclophosphamide; Diethylstilbestrol; Estrogens; Female; Fluorouracil; Fluoxymesterone; Humans; Mechlorethamine; Methotrexate; Testosterone; Thiotepa; Vinblastine; Vincristine | 1968 |
In vivo prediction of drug sensitivity with cancer-seeking isotopes.
Topics: Amides; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma 256, Walker; Cyclophosphamide; Deoxyuridine; Diethylstilbestrol; Female; Fluorouracil; Fluoxymesterone; Humans; Imidazoles; Iodine Radioisotopes; Methotrexate; Neoplasms; Nitrosourea Compounds; Phosphates; Rats; Serum Albumin, Radio-Iodinated; Sodium Isotopes; Triazenes; Vincristine | 1971 |
[Effects of the therapy combined with oophorectomy for the advanced breast cancer].
Topics: Abdominal Neoplasms; Adult; Age Factors; Antineoplastic Agents; Breast Neoplasms; Castration; Dexamethasone; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Metastasis; Ovary; Prognosis; Skin Neoplasms | 1971 |
Metastatic calcification of the myocardium.
Topics: Adult; Autopsy; Breast Neoplasms; Calcinosis; Carcinoma; Cardiomyopathies; Female; Fluoxymesterone; Humans; Hypercalcemia; Medroxyprogesterone; Myocardium; Necrosis; Phosphates; Prednisone | 1970 |
[The mammography--a criterion in hormonal by treated mastopathy].
Topics: Adenofibroma; Adenoma; Adult; Breast Neoplasms; Carcinoma; Cell Transformation, Neoplastic; Cystadenoma; Female; Fluoxymesterone; Humans; Mammography; Middle Aged; Papilloma; Prognosis | 1970 |
[Supplemental hormone treatment of operable breast neoplasms].
Topics: Adrenalectomy; Aged; Androgens; Breast Neoplasms; Female; Fluoxymesterone; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Ovary; Sex Chromatin; Testosterone | 1970 |
A radioisotopic method for determining optimum non-surgical therapy for advanced cancer. II. Clinical experience.
Topics: Adenocarcinoma; Breast Neoplasms; Diethylstilbestrol; Female; Fluorouracil; Fluoxymesterone; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Methods; Methotrexate; Neoplasm Metastasis; Phosphorus Isotopes; Prednisone | 1968 |
[Hormone treatment of breast cancer in the advanced phase].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluoxymesterone; Gonadotropins; Humans; Lactones; Nandrolone; Phenanthrenes; Secosteroids; Testolactone; Testosterone | 1968 |